Apple Shares Face Pressure Amid AI Development Delays

Apple US0378331005

Apple's stock is experiencing a period of weakness, weighed down by reports of postponed artificial intelligence features. The shares closed at $255.78 on Monday, having shed nearly 8% of their value over the preceding week. Despite the company recently posting record revenues, investor sentiment is being tempered by software delays and increasing costs for key components.

The recent share price decline reflects growing market apprehension regarding Apple's profitability and execution capabilities. Since the start of the year, the equity has declined by 5.83%. While Apple announced record first-quarter earnings of $143.8 billion in late January, the cost side of the equation is causing concern. Prices for NAND flash memory chips are climbing, with forecasts pointing to a quarter-over-quarter increase of 55-60% in contract prices. This upward pressure on component costs is directly impacting hardware margins.

On the hardware front, the company's schedule appears on track. Apple is set to unveil new products on March 4, with simultaneous events planned for New York, London, and Shanghai. Anticipated launches include MacBooks featuring the M5 chip and the iPhone 17e. Furthermore, the tech giant is expanding its services business; starting with iOS 26.4, Apple Podcasts will support video playback.

Staggered Rollout for Key Siri Upgrade

A major update to Siri has been delayed. The "Linwood" architecture, which is central to "Apple Intelligence 2.0" and was initially slated for March, has been pushed back. Instead of launching with iOS 26.4 in March, the new AI functionalities will now be introduced in stages. The rollout is expected to span from iOS 26.5 in May through to iOS 27 in September 2026.

Key Data Points:

• Current Share Price: $255.78 (as of February 16, 2026)
• Weekly Performance: -8%
• Q1 2026 Revenue: $143.8 billion
• Next Key Event: Product launch event on March 4, 2026
• Dividend: $0.26 per share (paid on February 12)

Despite these headwinds, analyst outlook remains cautiously optimistic. The average price target sits around $292, representing a potential upside of approximately 14% from current levels. However, the combination of delayed AI monetization and rising input costs is dampening the near-term mood. The upcoming product presentation in early March may provide a fresh catalyst for the stock.